All In Biotech

Drug Trial Radar · NCT05021120

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours

A Phase 1a/1b, Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumour Activity of AK127 in Combination With AK104 in Subjects With Advanced or Metastatic Solid Tumours

Last checked: Nov 19, 2026Latest source record: Dec 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

67

Actual

Start

Oct 12, 2021

Primary completion

Oct 1, 2024

Study completion Apr 1, 2025

Sponsor

Lead sponsor
Akesobio Australia Pty LtdIndustry
Sponsor type
Industry
First posted
Aug 25, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 1 study to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics, and preliminary antitumor activity of AK127 in combination with AK104.

Conditions

  • Advanced or Metastatic Solid Tumours

Interventions

  • AK127Drug

    Subjects will receive AK127 by intravenous administration

  • AK104Drug

    After AK127 infusion, on the same day subjects will receive AK104 by intravenous administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence and Nature of Adverse Events (AEs)Time frame: From the time of informed consent signed through to 90 days after end of treatment
  2. Number of participants with a Dose Limiting Toxicity (DLT)Time frame: Within the first six weeks of treatment

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Ashford Cancer Centre Research

    Adelaide, Australia

  • Austin Health

    Melbourne, Australia

  • Monash Health

    Melbourne, Australia

  • Southside Cancer Care Centre

    Sydney, Australia

  • The Kinghorn Cancer Centre, St Vincents Hospital Sydney

    Sydney, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.